Antitumor activity of temozolomide combined with irinotecan is partly independent of O6-methylguanine-DNA methyltransferase and mismatch repair phenotypes in xenograft models.

Source:http://linkedlifedata.com/resource/pubmed/id/11051264

Download in:

View as

General Info

PMID
11051264